Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.6622
+0.0200 (3.11%)
At close: Aug 24, 2026, 4:00 PM EDT
0.6678
+0.0056 (0.85%)
After-hours: Aug 24, 2026, 7:47 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $183.96 million as of August 24, 2026. Its market cap has decreased by -26.48% in one year.
Market Cap
183.96M
Enterprise Value
170.93M
1-Year Change
-26.48%
Ranking
Category
Stock Price
$0.66
ChartMarket Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $183.96M, an increase of 47.99%. That is a compound annual growth rate of 7.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 183.96M | -0.76% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Korro Bio | 194.08M |
| Protalix BioTherapeutics | 191.76M |
| Nkarta | 190.52M |
| Armata Pharmaceuticals | 189.63M |
| Codexis | 182.87M |
| Caribou Biosciences | 177.96M |
| Canton Strategic Holdings | 174.50M |
| Indaptus Therapeutics | 171.88M |